May 17, 2017 A recent press release from Athera Biotechnologies describes how Olink panels were used to measure 251 proteins in a longitudinal study of
Athera Biotechnologies utvecklar en läkemedelskandidat för en indikation inom hjärt-kärlsjukdomar där det idag saknas tillräcklig behandling. Efter framgångsrika fas 1-studier har nu bolaget rest kapital för att genomföra en klinisk fas 2-studie varpå förvärv från ett större läkemedelsbolag förväntas.
Fördelningen i styrelsen är 100,0 % män (4), 0,0 % kvinnor (0) . Ansvarig är James Anthony Hall 49 år. På Ratsit hittar du Telefonnummer Adress Årsredovisning m.m. Alltid uppdaterat. Athera Biotechnologies AB (Athera) is a clinical stage biopharmaceutical company that focuses on the development of anti-inflammatory biological candidate drugs for the prevention and treatment of im Athera Biotechnologies.
Största aktieägare är Industrifonden, Östersjöstiftelsen och Linc AB. Athera har precis avslutat en emission med Sciety. Taggar: Pågående uppdrag: Styrelseordförande i Athera Biotechnologies AB. Styrelseledamot i Olsson Solutions AB, IRLAB Sweden, Gesynta Pharma AB, European Society of Cardiology och Hjärt-Lungfonden Svenska Nationalföreningen mot hjärt- och lungsjukdomar. Aktieinnehav: 2 000 A-aktier. 2019-05-21 About Athera Biotechnologies .
Athera Biotechnologies AB Olof Palmes gata 29, 4th floor 111 22 Stockholm, Sweden. James Hall, CEO E-mail: j.hall@athera.se. Reg. No. 556620-6859
Athera Biotechnologies AB | 871 followers on LinkedIn. Clinical stage development of anti-inflammatory antibody therapeutics for treatment of immunovascular disease Athera is a clinical stage Athera Biotechnologies AB,556620-6859 - På allabolag.se hittar du , bokslut, nyckeltal, styrelse, Status, adress mm för Athera Biotechnologies AB Athera Biotechnologies Ab is a biopharmaceutical company.
Athera has an agreement with Richter-Helm BioLogics GmbH & Co. KG in Hamburg, Germany, for the process development of the product. About Athera Biotechnologies. Athera has a unique and in-depth understanding of the immunological components in atherosclerosis, the inflammatory process leading to cardiovascular disease (CVD).
Phone Number +46761938190 Athera is a biopharmaceutical company focused on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics for the prevention and treatment of cardiovascular disease (“CVD”). Description Operator of biopharmaceutical company intended to address the large unmet need for anti-inflammatory therapeutics in the treatment of cardiovascular disease (CVD). At Athira, We Value Connections Athira is derived from the word Athir, the energy that reaches everyone. It captures our mission to develop therapies that can reach and positively impact everyone.
Dec 28, 2020 Subsequently mice were treated with 10-mg/kg PC-mAb (also known as ATH3G10) (Athera Biotechnologies AB, Stockholm, Sweden) every
BIOTECH IN EUROPE INVESTOR FORUM Alexey Eliseev, Managing Director, Maxwell Biotech Carina Schmidt, CEO, Athera Biotechnologies AB.
Oct 14, 2010 Dr Nordzell and Dr Pettersson are employees of Athera Biotechnologies ( Stockholm, Sweden), and Dr Frostegård is a minor shareholder in
Apr 24, 2020 Active Biotech AB (publ) (NASDAQ Stockholm: ACTI) is a biotechnology company with focus on autoimmune /inflammatory diseases and
May 2, 2018 Athera is Foundry's new cloud platform that allows you to create and collaborate on VFX projects from anywhere, scaling your resources up and
Jun 4, 2020 The foundation of Athira Pharma began while Leen Kawas was earning her Ph.D .
Biologiska fordonet
Stockholm December 3, 2015 Athera Biotechnologies AB, a privately held biopharmaceutical company focused on developing a new antibody against cardiovascular diseases, has completed a 24 million SEK financing from a consortium led by The Foundation for Baltic and East European Studies (Östersjöstiftelsen), Industrifonden and Linc Invest.
VD:.
Sciety-nätverket investerar i Athera Biotechnologies tillsammans med Industrifonden, Östersjöstiftelsen och Linc. Athera påbörjade nyligen kliniska fas
Biography.
Arkitektur och teknik jobb
utbildning vård och omsorg
quality assurance jobb
danderyd at ansökan
gislaved invånare
Athera Biotechnologies AB är ett privatägt läkemedelsutvecklingsföretag inriktat på utveckling av antikroppsterapi mot hjärt-kärlsjukdomar. Industrifonden deltar i den finansieringsrunda om 24 miljoner kronor som leds av Industrifonden tillsammans med Östersjöstiftelsen och Linc Invest.
Molecular Biology. Global Experts from Athera Biotechnologies AB. F-skatt.